| A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II YJ Kim, S Björklund, Y Li, MH Sayre, RD Kornberg Cell 77 (4), 599-608, 1994 | 1444 | 1994 |
| RSC, an essential, abundant chromatin-remodeling complex BR Cairns, Y Lorch, Y Li, M Zhang, L Lacomis, H Erdjument-Bromage, ... Cell 87 (7), 1249-1260, 1996 | 899 | 1996 |
| A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme BØ Wittschieben, G Otero, T de Bizemont, J Fellows, ... Molecular cell 4 (1), 123-128, 1999 | 582 | 1999 |
| Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation G Otero, J Fellows, Y Li, T de Bizemont, AMG Dirac, CM Gustafsson, ... Molecular cell 3 (1), 109-118, 1999 | 582 | 1999 |
| Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids H Ge, X Li, J Weiszmann, P Wang, H Baribault, JL Chen, H Tian, Y Li Endocrinology 149 (9), 4519-4526, 2008 | 535 | 2008 |
| Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects J Xu, S Stanislaus, N Chinookoswong, YY Lau, T Hager, J Patel, H Ge, ... American Journal of Physiology-Endocrinology and Metabolism 297 (5), E1105-E1114, 2009 | 418 | 2009 |
| T0070907, a selective ligand for peroxisome proliferator-activated receptor γ, functions as an antagonist of biochemical and cellular activities G Lee, F Elwood, J McNally, J Weiszmann, M Lindstrom, K Amaral, ... Journal of Biological Chemistry 277 (22), 19649-19657, 2002 | 367 | 2002 |
| Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme Y Li, S Bjorklund, YW Jiang, YJ Kim, WS Lane, DJ Stillman, RD Kornberg Proceedings of the National Academy of Sciences 92 (24), 10864-10868, 1995 | 314 | 1995 |
| CTD kinase associated with yeast RNA polymerase II initiation factor b WJ Feaver, O Gileadi, Y Li, RD Kornberg Cell 67 (6), 1223-1230, 1991 | 292 | 1991 |
| Structural organization of yeast and mammalian mediator complexes MR Dotson, CX Yuan, RG Roeder, LC Myers, CM Gustafsson, YW Jiang, ... Proceedings of the National Academy of Sciences 97 (26), 14307-14310, 2000 | 266 | 2000 |
| RNA polymerase II initiation factor interactions and transcription start site selection Y Li, PM Flanagan, H Tschochner, RD Kornberg Science 263 (5148), 805-807, 1994 | 237 | 1994 |
| Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex IN Foltz, S Hu, C King, X Wu, C Yang, W Wang, J Weiszmann, J Stevens, ... Science translational medicine 4 (162), 162ra153-162ra153, 2012 | 232 | 2012 |
| FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation X Wu, H Ge, B Lemon, S Vonderfecht, J Weiszmann, R Hecht, J Gupte, ... Journal of Biological Chemistry 285 (8), 5165-5170, 2010 | 218 | 2010 |
| SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase JP Powers, DE Piper, Y Li, V Mayorga, J Anzola, JM Chen, JC Jaen, ... Journal of medicinal chemistry 49 (3), 1034-1046, 2006 | 170 | 2006 |
| Co-receptor requirements for fibroblast growth factor-19 signaling X Wu, H Ge, J Gupte, J Weiszmann, G Shimamoto, J Stevens, N Hawkins, ... Journal of Biological Chemistry 282 (40), 29069-29072, 2007 | 169 | 2007 |
| Evidence for a mediator cycle at the initiation of transcription JQ Svejstrup, Y Li, J Fellows, A Gnatt, S Bjorklund, RD Kornberg Proceedings of the National Academy of Sciences 94 (12), 6075-6078, 1997 | 159 | 1997 |
| Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2 T Lee, R Schwandner, G Swaminath, J Weiszmann, M Cardozo, ... Molecular pharmacology 74 (6), 1599-1609, 2008 | 158 | 2008 |
| INT131: a selective modulator of PPARγ A Motani, Z Wang, J Weiszmann, LR McGee, G Lee, Q Liu, J Staunton, ... Journal of molecular biology 386 (5), 1301-1311, 2009 | 144 | 2009 |
| Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses WN D’Souza, J Douangpanya, S Mu, P Jaeckel, M Zhang, JR Maxwell, ... PLoS One 12 (7), e0180190, 2017 | 133 | 2017 |
| Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice X Li, H Ge, J Weiszmann, R Hecht, Y Li, MM Véniant, J Xu, X Wu, ... FEBS letters 583 (19), 3230-3234, 2009 | 133 | 2009 |
